S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

PCRX Pacira BioSciences Inc

17.81

0.90 (5.32%)

After Hours

Last Updated: 15:21:25

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Pacira BioSciences Charts.

Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Pacira BioSciences Charts.

Pacira BioSciences Inc News

Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
Thursday 14 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
Tuesday 12 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Pacira BioSciences Reports Third Quarter 2024 Financial Results
Wednesday 6 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings
Monday 4 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024
Wednesday 30 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 23 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 21 October 2024 (1 month ago) • Edgar (US Regulatory)

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
Monday 21 October 2024 (1 month ago) • GlobeNewswire Inc.

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Monday 7 October 2024 (2 months ago) • GlobeNewswire Inc.

More Pacira BioSciences Inc News Articles

Arista Networks

Fundo Invest Financeiro ...

M.DIAS BRANCO ON

Bnp Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions